1) Fibrosing cholestatic hepatitis
纤维化淤胆性肝炎
2) biliary fibrosis
淤胆性肝纤维化
1.
Effects of nitric oxide and endothelin-1 on biliary fibrosis in rats;
一氧化氮和内皮素-1在淤胆性肝纤维化中的作用机制
3) cholestasis-induced liver fibrosis
胆汁淤积性肝纤维化
1.
Effect of chinese medicine Complex prescriptions of different cure laws on PAI-1 mRNA of cholestasis-induced liver fibrosis rat;
不同治则中药复方对胆汁淤积性肝纤维化大鼠PAI-1影响的研究
2.
Objective To study the regulatory effects of the Chinese medicine complex prescriptions Erzhiwan and Shixiaosan on urokinase type plasminogen activator(uPA)/plasminogen activator inhibitor-1(PAI-1)fibrinolytic system cholestasis-induced liver fibrosis rats.
目的研究不同治则中药复方二至丸与失笑散对胆汁淤积性肝纤维化大鼠uPA/PAI-1纤溶途经的调控作用。
3.
Objective To study the effects of the Chinese herbal compound (Erzhiwan, Shixiaosan and combined formula) on cholestasis-induced liver fibrosis rat’s uPA.
目的观察补益肝肾、活血化瘀方二至丸、失笑散及其合方对胆汁淤积性肝纤维化大鼠肝组织尿激酶型纤溶酶原激活剂(uPA)的影响。
4) chronic cholestatic hepatitis
慢性淤胆型肝炎
1.
Therapeutic effect of ligustrazine together with heparin sodium and ursodeoxycholic acid (UDCA) on chronic cholestatic hepatitis.;
川芎嗪注射液联合肝素钠与口服熊去氧胆酸治疗慢性淤胆型肝炎疗效观察
2.
The subject was divided into two parts: The first part:Clinical effect of Yudan decoction on intrahepatic cholestatic jaundice Objective: To observe the therapeutic effect of Yudan decoction in treating jaundice caused by chronic cholestatic hepatitis, and to explore its mechanism preliminarily.
第一部分:愈疸汤治疗肝内胆汁淤积性黄疸的临床观察 目的:观察愈疸汤治疗慢性淤胆型肝炎的退黄效果,并初步探讨其机理。
5) acute viral cholestatic hepatitis
急性淤胆型肝炎
6) chronic hepatitis and hepatic fibrosis
慢性肝炎肝纤维化
1.
The footing of this thesis are evolution of all kinds of pathogenesis factors in the development of chronic hepatitis and hepatic fibrosis.
探讨慢性肝炎肝纤维化进程中各种病机要素的演变规律。
补充资料：慢性活动性病毒性肝炎
慢性活动性病毒性肝炎
病名。病毒性肝 炎类型之一。详见该条 。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条